Login / Signup

p53 downregulates PD-L1 expression via miR-34a to inhibit the growth of triple-negative breast cancer cells: a potential clinical immunotherapeutic target.

Siyu DengMengna WangChenglong WangYan ZengXue QinYiwen TanBing LiangYoude Cao
Published in: Molecular biology reports (2022)
Our research may provide a novel potential target for TNBC.
Keyphrases
  • breast cancer cells
  • cell proliferation
  • long non coding rna
  • human health